GHK-Cu 50MG

The GHK tripeptide was first identified as a plasma factor whose levels decline with age, a finding that launched decades of investigation into copper-peptide biology. When complexed with copper, GHK becomes GHK-Cu — a molecule studied for its ability to modulate gene-expression patterns in dermal fibroblasts, including genes associated with collagen production, matrix metalloproteinases, and antioxidant defenses. In wound-healing models, researchers have examined its influence on the successive phases of tissue repair, from inflammatory signaling through remodeling. What distinguishes GHK-Cu in the literature is the sheer breadth of its published data: few research peptides have been characterized across as many cell types and endpoints. This 50MG format is the standard presentation for laboratories conducting fibroblast assays, gene-expression profiling, or comparative studies within copper-peptide families. Analytical documentation confirms sequence, purity, and copper complexation. Plasma-level decline with age, reported in the early literature, continues to motivate basic research into endogenous copper-peptide physiology. For laboratory research use only. Not for human or veterinary use.